Biomarker Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Name	Title	Email/Phone
1 James Fallon	VP Engineering	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Endpoint	$60.6M	323	-6%	N/A	N/A
#2 eClinicalWorks	$907.8M	4472	N/A	N/A	N/A
#3 Allscripts	$1500M	5889	-10%	$100M	$2.2B
#4 Practice Fusion	$16.4M	117	-6%	$157.5M	N/A
#5 Vitera Healthca...	$15.9M	122	-1%	N/A	N/A
#6 Office Ally	$45.3M	284	25%	N/A	N/A
#7 AdvancedMD	$143.1M	705	3%	N/A	N/A
#8 drchrono	$24.4M	162	-8%	$60.7M	N/A
#9 Modernizing Med...	$333.7M	1667	8%	$332.6M	$1B
#10 iPatientCare	$23.3M	146	N/A	N/A	N/A
#11 Welligent	$5.8M	50	N/A	N/A	N/A
#12 T-System	$395M	1045	N/A	N/A	N/A
#13 Evident	$206.9M	613	N/A	N/A	N/A
#14 Nextech Systems	$83.4M	453	9%	$10.7M	N/A
#15 Meditab Softwar...	$207.2M	614	27%	N/A	N/A
#16 Procentive	$3.6M	31	-9%	N/A	N/A
#17 FutureNet	$64.9M	358	N/A	N/A	N/A
#18 iSALUS healthca...	$62.4M	210	N/A	N/A	N/A
#19 QHR Technologie...	$78.8M	435	-1%	N/A	N/A
#20 CliniComp Intl.	$27.9M	175	N/A	N/A	N/A

keywords:N/A

N/A

Total Funding

Number of Employees

$3.7M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Outsourcing-Pharma recently spoke with David Liu, CEO of health technology company Sonde Health, about the potential of vocal biomarkers in...

"Our biomarker for early-stage Alzheimer's disease represents new thinking and is unique from the amyloid-beta and p-tau molecules that are...

Last year, Owkin received a $180 million investment from Sanofi in a deal that includes biomarker discovery. Owkin said that the investment made...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Chewse	$3.2M	24	-8%	$33.9M
#2 Compass Analyti...	$2.2M	24	-17%	N/A
#3 RevelOne	$2M	24	0%	N/A
#4 Subspace	$5M	24	9%	N/A
#5 paubox	$2.4M	24	N/A	N/A